Business · 01/06/2026
FDA Classifies Oropharyngeal Electrical Stimulator as Class II Device
The FDA has classified the oropharyngeal electrical stimulator as a Class II device, which will provide a reasonable assurance of safety and effectiveness, and is expected to enhance patients' access to innovative devices by reducing regulatory burdens.
Original source language: Federal Register — Health and Human ServicesOpen original release →